December 21, 2022
From a billion-dollar deal in Delaware to a hard-fought battle over a bribery scandal involving Ohio's legislature, securities litigators secured big settlements this year that sprang from both class actions and derivative suits, with a high number of resolutions occurring in Delaware Chancery Court.
October 17, 2022
Attorneys representing a proposed class of investors in pharmacy chain Walgreens will receive nearly $29 million for their work on a suit alleging the company painted an overly rosy picture of its finances in an effort to convince shareholders to vote in favor of the completion of its acquisition of Swiss-based pharmacy company Alliance Boots GmbH.
September 06, 2022
Attorneys representing investors in a suit claiming Walgreens touted overly rosy financial projections in seeking shareholder approval of its plan to acquire a Swiss-based pharmacy chain operator have asked an Illinois federal judge to sign off on their request for roughly $29 million in fees following a $105 million settlement with the pharmacy chain.
June 24, 2022
Pharmacy chain Walgreens and two of its former executives have agreed to pay $105 million to end investor claims the company touted overly rosy financial projections as it sought shareholder approval of its plan to complete the acquisition of Swiss-based pharmacy chain operator Alliance Boots GmbH.
November 03, 2021
An Illinois federal judge on Tuesday pared back class claims brought by Walgreens investors claiming the pharmacy retail chain and two former executives inflated its earning goal, partially granting summary judgment in the company's favor while finding that a number of claims belong before a jury.
September 24, 2019
An Illinois federal judge refused Monday to dismiss most of the amended claims brought by Walgreens investors who say the company and two former executives inflated the company's earnings goal, after initially throwing out the bulk of the suit.
February 20, 2019
Walgreens and two of its former executives asked an Illinois federal judge on Tuesday to toss an amended stock-drop suit alleging they lied about the company's financial health, saying investors can't revive earlier claims based on Walgreens' recent $34.5 million settlement with the U.S. Securities and Exchange Commission.
March 30, 2018
An Illinois federal judge on Thursday certified a class of investors suing Walgreen Co. for allegedly deceiving them about the company's financial health as drug prices increased, saying the class met the hurdles for size and common claims and that the possible inadequacy of the lead plaintiff wasn't enough to prevent certification.
May 01, 2017
An Illinois federal judge ruled Friday that a proposed class of investors cannot have access to Walgreen Co.'s internal documents regarding its purchase of a health and beauty company that did not prove to be as profitable as promised, in a suit claiming the pharmacy giant deceived the investors.
September 30, 2016
An Illinois federal judge on Friday allowed Walgreen Co. to escape most of a proposed investor class action accusing the pharmacy and two former executives of deceiving investors in relation to the purchase of Alliance Boots GmbH, saying they failed to show the misleading nature of many of the statements at issue.